share_log

Could The Market Be Wrong About 3SBio Inc. (HKG:1530) Given Its Attractive Financial Prospects?

Could The Market Be Wrong About 3SBio Inc. (HKG:1530) Given Its Attractive Financial Prospects?

鉴于其诱人的财务前景,市场对3sBio Inc.(HKG: 1530)的看法会错吗?
Simply Wall St ·  01/24 02:30

3SBio (HKG:1530) has had a rough month with its share price down 11%. But if you pay close attention, you might gather that its strong financials could mean that the stock could potentially see an increase in value in the long-term, given how markets usually reward companies with good financial health. In this article, we decided to focus on 3SBio's ROE.

3sBio(HKG: 1530)经历了艰难的一个月,其股价下跌了11%。但是,如果你密切关注,你可能会发现,鉴于市场通常会奖励财务状况良好的公司,其强劲的财务状况可能意味着该股的长期价值可能会增加。在本文中,我们决定重点关注3sBio的投资回报率。

Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. Put another way, it reveals the company's success at turning shareholder investments into profits.

股本回报率或投资回报率是用于评估公司管理层利用公司资本效率的关键指标。换句话说,它揭示了公司成功地将股东投资转化为利润。

View our latest analysis for 3SBio

查看我们对3sBio的最新分析

How Do You Calculate Return On Equity?

你如何计算股本回报率?

The formula for return on equity is:

股本回报率的公式是:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

股本回报率 = 净利润(来自持续经营业务)÷ 股东权益

So, based on the above formula, the ROE for 3SBio is:

因此,根据上述公式,3sBio的投资回报率为:

12% = CN¥1.9b ÷ CN¥16b (Based on the trailing twelve months to June 2023).

12% = 19亿元人民币 ÷ 160亿元人民币(基于截至2023年6月的过去十二个月)。

The 'return' refers to a company's earnings over the last year. So, this means that for every HK$1 of its shareholder's investments, the company generates a profit of HK$0.12.

“回报” 是指公司去年的收益。因此,这意味着该公司每投资1港元,就会产生0.12港元的利润。

Why Is ROE Important For Earnings Growth?

为什么投资回报率对收益增长很重要?

We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don't share these attributes.

我们已经确定,投资回报率是衡量公司未来收益的有效盈利指标。现在,我们需要评估公司再投资或 “保留” 了多少利润以用于未来的增长,从而使我们对公司的增长潜力有所了解。一般而言,在其他条件相同的情况下,股本回报率和利润留存率高的公司的增长率要高于不具有这些属性的公司。

3SBio's Earnings Growth And 12% ROE

3sBio的收益增长和12%的投资回报率

To begin with, 3SBio seems to have a respectable ROE. On comparing with the average industry ROE of 9.0% the company's ROE looks pretty remarkable. Probably as a result of this, 3SBio was able to see a decent growth of 13% over the last five years.

首先,3sBio的投资回报率似乎相当不错。与9.0%的行业平均投资回报率相比,该公司的投资回报率看起来相当可观。可能是由于这个原因,3sBio得以在过去五年中实现了13%的可观增长。

As a next step, we compared 3SBio's net income growth with the industry, and pleasingly, we found that the growth seen by the company is higher than the average industry growth of 11%.

下一步,我们将3sBio的净收入增长与该行业进行了比较,令人高兴的是,我们发现该公司的增长高于11%的行业平均增长。

past-earnings-growth
SEHK:1530 Past Earnings Growth January 24th 2024
SEHK: 1530 过去的收益增长 2024 年 1 月 24 日

Earnings growth is a huge factor in stock valuation. It's important for an investor to know whether the market has priced in the company's expected earnings growth (or decline). Doing so will help them establish if the stock's future looks promising or ominous. One good indicator of expected earnings growth is the P/E ratio which determines the price the market is willing to pay for a stock based on its earnings prospects. So, you may want to check if 3SBio is trading on a high P/E or a low P/E, relative to its industry.

收益增长是股票估值的重要因素。对于投资者来说,重要的是要知道市场是否对公司的预期收益增长(或下降)进行了定价。这样做将帮助他们确定股票的未来是乐观还是不祥的。衡量预期收益增长的一个很好的指标是市盈率,它根据收益前景决定了市场愿意为股票支付的价格。因此,您可能需要检查3sBio相对于其行业是以高市盈率还是低市盈率进行交易。

Is 3SBio Making Efficient Use Of Its Profits?

3sBio是否在有效利用其利润?

3SBio's three-year median payout ratio to shareholders is 22% (implying that it retains 78% of its income), which is on the lower side, so it seems like the management is reinvesting profits heavily to grow its business.

3sBio的三年股东派息率中位数为22%(这意味着它保留了78%的收入),处于较低水平,因此管理层似乎正在大量再投资利润以发展业务。

Moreover, 3SBio is determined to keep sharing its profits with shareholders which we infer from its long history of six years of paying a dividend. Upon studying the latest analysts' consensus data, we found that the company is expected to keep paying out approximately 19% of its profits over the next three years. Therefore, the company's future ROE is also not expected to change by much with analysts predicting an ROE of 13%.

此外,3sBio决心继续与股东分享利润,这是我们从其六年支付股息的长期历史中推断出来的。在研究了分析师的最新共识数据后,我们发现该公司预计将在未来三年内继续支付约19%的利润。因此,预计该公司未来的投资回报率也不会有太大变化,分析师预计投资回报率为13%。

Conclusion

结论

Overall, we are quite pleased with 3SBio's performance. Specifically, we like that the company is reinvesting a huge chunk of its profits at a high rate of return. This of course has caused the company to see substantial growth in its earnings. That being so, a study of the latest analyst forecasts show that the company is expected to see a slowdown in its future earnings growth. Are these analysts expectations based on the broad expectations for the industry, or on the company's fundamentals? Click here to be taken to our analyst's forecasts page for the company.

总的来说,我们对3sBio的表现非常满意。具体而言,我们喜欢该公司以高回报率再投资其利润的很大一部分。当然,这导致该公司的收益大幅增长。既然如此,对分析师最新预测的研究表明,预计该公司未来的收益增长将放缓。这些分析师的预期是基于对该行业的广泛预期,还是基于公司的基本面?点击此处进入我们分析师对公司的预测页面。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发